findmyKOL

Donald Tashkin, MD

Enriched profile

Distinguished Emeritus Professor of Medicine, Division of Pulmonary and Critical Care Medicine · David Geffen School of Medicine at UCLA

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Los Angeles, CA · West · United StatesSpecialtyPulmonary DiseaseFocusAsthma+2
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1985–2012

Donald Tashkin is Distinguished Emeritus Professor of Medicine, Division of Pulmonary and Critical Care Medicine at David Geffen School of Medicine at UCLA. OpenAlex indexes 873 publications with 42,971 citations (h-index 108); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Pulmonary Disease profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Donald Tashkin, MD, is Distinguished Emeritus Professor of Medicine, Division of Pulmonary and Critical Care Medicine at David Geffen School of Medicine at UCLA. The public record shows 873 publications with 42,971 citations (h-index 108), centered on Asthma, COPD, Idiopathic Pulmonary Fibrosis. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 6 companies, 13 NIH-funded awards (1985–2012).

  • Most recent indexed publication: 2026 · International journal of chronic obstructive pulmonary disease
  • Top research focus: Asthma
  • 6 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
COPD3 trialsLung Diseases2 trialsIdiopathic Pulmonary Fibrosis1 trialLung Diseases, Interstitial1 trialRespiratory Insufficiency1 trialAsthma1 trialEmphysema1 trialBronchitis, Chronic1 trialBronchitis1 trial

Research focus

OpenAlex concept fingerprint
AsthmaCOPDIdiopathic Pulmonary Fibrosis

Drugs & molecules

across trials, industry payments and publications
Dupixentgeneric · DupilumabClinical trials—Industry payments7Publications—Yupelrigeneric · RevefenacinClinical trials—Industry payments3Publications—Ofevgeneric · NintedanibClinical trials—Industry payments2Publications—Spirivageneric · TiotropiumClinical trials—Industry payments1Publications—Stiolto RespimatClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trials—Industry payments9Genzyme CorporationClinical trials—Industry payments7Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments3Mylan Specialty L.P.Clinical trials—Industry payments3University of California, Los AngelesClinical trials2Industry payments—Boehringer Ingelheim International GmbHClinical trials—Industry payments1Chiesi Farmaceutici S.p.A.Clinical trials1Industry payments—Duke UniversityClinical trials1Industry payments—EmphycorpClinical trials1Industry payments—Michael RothClinical trials1Industry payments—Mylan Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
873publications

Distinct works indexed by OpenAlex, matched via ORCID; 26 in PubMed.

42,971citations

Total citations across indexed works.

108h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6clinical trials

Investigator role on registered studies.

View trials ↓
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
13NIH grants · 1985–2012

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2020)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Genitourinary & hormones

    100%
    5-alpha Reductase Inhibitor100%
    Finasteride100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 14 Oct 2026

13 NIH research awards on record, funded 1985–2012 per NIH RePORTER. The latest:

All 85 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/donald-tashkin-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • Other

    ucla.researcherprofiles.org/donald.tashkin

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucla.researcherprofiles.org ↗
  • ResearchGate

    researchgate.net/profile/Donald-Tashkin

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    University of Pennsylvania School of Medicine

    1961
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →24-7pressrelease.com ↗
  • BA in Chemistry

    University of Pennsylvania

    1957
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →24-7pressrelease.com ↗
  • Diplomate

    American Board of Internal Medicine (Internal Medicine and Pulmonary Disease)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →24-7pressrelease.com ↗

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Expert Research Advisor

    CTD-ILD (Connective Tissue Disease-associated Interstitial Lung Disease) Program, UCLA Health

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →uclahealth.org ↗
  • Attending physician

    Ronald Reagan UCLA Medical Center

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.